I have posted my notes on today's Cantel Medical (CMN) analyst conference call here:
Cantel Medical fiscal third quarter 2013
Cantel had a good, but not spectacular, quarter.
I own stock in CMN. I have watched them expand revenue in the healthcare infection-prevention market for several years now. I see no reason Cantel should not continue to do well these next few years and see a gradual but significant rise in the stock price.
I hope to post a longer analysis at Seeking Alpha sometime today or tormorrow.